About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
D
Metastatic Evaluation after Melanoma Treatment Including the Risk of a Second Primary
By
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
FEATURING
Daniel Zelac
By
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
FEATURING
Daniel Zelac
311 views
February 7, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
10:01
AAD 2024 Insights
AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma
Feat.
V. Sondak
12:46
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …
Feat.
A. Betof Warner
24:14
Masterclasses in Dermatology
Advances in the Treatment of Melanoma
Feat.
D. Fisher
20:55
2023 West Oncology Conference
2023 West Oncology Conference: Melanoma Updates
Feat.
M. Mooradian
20:32
Melanoma Bridge 2023
Targeted Therapy in BRAF-Mutated Metastatic Melanoma
Feat.
R. Dummer
10:39
Moffitt Cancer Center
Clinical Implications of COMBI-d and COMBI-v Trials on OS in Patient…
Feat.
A. Tarhini
27:29
Total Health
2023 ASCO® Direct Philadelphia: Melanoma Updates
Feat.
M. Orloff
07:53
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "aTezolizumab, bevAcizumab, and Cobimetinib…
Feat.
E. Burton
12:09
Omid Hamid
Evolving Management of Melanoma CNS Metastases and the Impact of COM…
25:21
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
Treatment of Advanced Melanoma in 2023
Feat.
K. Bollin
05:06
ASCO 2022 Conference Coverage
ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…
Feat.
P. Rutkowski
15:46
Melanoma Bridge 2023
Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…
Feat.
H. Tawbi
07:25
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Brain Metastases & Survival Evaluation…
Feat.
P. Ascierto
24:53
OncoAlert
Recent Melanoma Updates
Feat.
A. Betof Warner
11:55
Winship Melanoma and Cutaneous Oncology Symposium
52 y/o Male With Newly Diagnosed Metastatic Melanoma: Case Discussion
Feat.
M. Yushak,
R. Sinha,
S. Patel,
J. Mehnert
02:36
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
2024 Neuro-Oncology Update: Melanoma and Brain Mets
Feat.
T. McGranahan
10:11
Memorial Sloan Kettering Cancer Center
2022 Updates in the Treatment of Melanoma
Feat.
M. Postow
08:59
Insights from 2023 Society for Melanoma Research Annual Meeting
2023 SMR Congress Insights: "Study of DYP688, an ADC Delivering…
Feat.
M. Carlino
15:48
Insights from 2023 SITC Annual Meeting
SITC 2023 Insights: "PERIO-01 Trial - Clinical Activity of SD-1…
Feat.
S. Patel
20:08
NYU Langone
Treatment Questions for Medical Oncologists Treating Melanoma
Feat.
J. Weber
